Synairgen plc

AIM:SNG Stok Raporu

Piyasa değeri: UK£9.6m

Synairgen Yönetim

Yönetim kriter kontrolleri 4/4

Synairgen's CEO is Richard Marsden, appointed in Sep 2009, has a tenure of 15.17 years. total yearly compensation is £328.00K, comprised of 94.5% salary and 5.5% bonuses, including company stock and options. directly owns 0.49% of the company’s shares, worth £47.45K. The average tenure of the management team and the board of directors is 3.8 years and 8.7 years respectively.

Anahtar bilgiler

Richard Marsden

İcra Kurulu Başkanı

UK£328.0k

Toplam tazminat

CEO maaş yüzdesi94.5%
CEO görev süresi15.2yrs
CEO sahipliği0.5%
Yönetim ortalama görev süresi3.8yrs
Yönetim Kurulu ortalama görev süresi8.7yrs

Son yönetim güncellemeleri

Recent updates

Here's Why We're Not Too Worried About Synairgen's (LON:SNG) Cash Burn Situation

Dec 09
Here's Why We're Not Too Worried About Synairgen's (LON:SNG) Cash Burn Situation

Here's Why We're Watching Synairgen's (LON:SNG) Cash Burn Situation

Aug 24
Here's Why We're Watching Synairgen's (LON:SNG) Cash Burn Situation

Is Synairgen (LON:SNG) In A Good Position To Invest In Growth?

Apr 29
Is Synairgen (LON:SNG) In A Good Position To Invest In Growth?

Companies Like Synairgen (LON:SNG) Could Be Quite Risky

Dec 27
Companies Like Synairgen (LON:SNG) Could Be Quite Risky

We're A Little Worried About Synairgen's (LON:SNG) Cash Burn Rate

Sep 13
We're A Little Worried About Synairgen's (LON:SNG) Cash Burn Rate

Companies Like Synairgen (LON:SNG) Could Be Quite Risky

May 31
Companies Like Synairgen (LON:SNG) Could Be Quite Risky

Here's Why We're Not Too Worried About Synairgen's (LON:SNG) Cash Burn Situation

Feb 06
Here's Why We're Not Too Worried About Synairgen's (LON:SNG) Cash Burn Situation

We're Hopeful That Synairgen (LON:SNG) Will Use Its Cash Wisely

Oct 21
We're Hopeful That Synairgen (LON:SNG) Will Use Its Cash Wisely

We're Hopeful That Synairgen (LON:SNG) Will Use Its Cash Wisely

Mar 29
We're Hopeful That Synairgen (LON:SNG) Will Use Its Cash Wisely

How Much Of Synairgen plc (LON:SNG) Do Institutions Own?

Dec 14
How Much Of Synairgen plc (LON:SNG) Do Institutions Own?

CEO Tazminat Analizi

Richard Marsden'un ücretlendirmesi Synairgen'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-UK£7m

Mar 31 2024n/an/a

-UK£8m

Dec 31 2023UK£328kUK£310k

-UK£8m

Sep 30 2023n/an/a

-UK£9m

Jun 30 2023n/an/a

-UK£10m

Mar 31 2023n/an/a

-UK£14m

Dec 31 2022UK£328kUK£310k

-UK£18m

Sep 30 2022n/an/a

-UK£23m

Jun 30 2022n/an/a

-UK£28m

Mar 31 2022n/an/a

-UK£38m

Dec 31 2021UK£1mUK£256k

-UK£49m

Sep 30 2021n/an/a

-UK£46m

Jun 30 2021n/an/a

-UK£43m

Mar 31 2021n/an/a

-UK£28m

Dec 31 2020UK£415kUK£194k

-UK£14m

Sep 30 2020n/an/a

-UK£10m

Jun 30 2020n/an/a

-UK£6m

Mar 31 2020n/an/a

-UK£5m

Dec 31 2019UK£289kUK£190k

-UK£4m

Sep 30 2019n/an/a

-UK£4m

Jun 30 2019n/an/a

-UK£4m

Mar 31 2019n/an/a

-UK£3m

Dec 31 2018UK£205kUK£186k

-UK£3m

Sep 30 2018n/an/a

-UK£898k

Jun 30 2018n/an/a

UK£2m

Mar 31 2018n/an/a

UK£2m

Dec 31 2017UK£336kUK£182k

UK£2m

Tazminat ve Piyasa: Richard's total compensation ($USD425.66K) is about average for companies of similar size in the UK market ($USD369.71K).

Tazminat ve Kazançlar: Richard's compensation has been consistent with company performance over the past year.

CEO

Richard Marsden (57 yo)

15.2yrs

Görev süresi

UK£328,000

Tazminat

Mr. Richard Marsden has been Chief Executive Officer of Synairgen Research Ltd since September 2009. Mr. Marsden has been Managing Director and Executive Director at Synairgen since June 2004 has been its...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Richard Marsden
CEO, MD & Executive Director15.2yrsUK£328.00k0.49%
£ 47.4k
Stephen Holgate
Co-Founderno dataUK£40.00k0.45%
£ 43.5k
Joseph Colliver
CFO & Executive Directorless than a yearUK£197.41kVeri yok
Phillip Monk
Chairman of Scientific Advisory Board15.2yrsUK£241.00k0.21%
£ 20.2k
Donna Davies
Co-Founder & Member of Scientific Advisory Boardno dataVeri yokVeri yok
Ratko Djukanovic
Co-Founder & Member of Scientific Advisory Boardno dataVeri yokVeri yok
Gareth Walters
Chief Regulatory Officer3.1yrsVeri yokVeri yok
Jody Brookes
Senior VP & Head of Clinical Operations12.9yrsVeri yokVeri yok
Richard Francis
Senior VP and Head of CMC & Quality3.2yrsVeri yokVeri yok
Victoria Tear
Head of Laboratory5.6yrsVeri yokVeri yok
Marcin Mankowski
Chief Medical Officer1.1yrsVeri yokVeri yok
Simon Holden
Company Secretary3.8yrsVeri yokVeri yok

3.8yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: SNG's management team is considered experienced (3.8 years average tenure).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Richard Marsden
CEO, MD & Executive Director20.4yrsUK£328.00k0.49%
£ 47.4k
Stephen Holgate
Co-Founder21.4yrsUK£40.00k0.45%
£ 43.5k
Joseph Colliver
CFO & Executive Directorless than a yearUK£197.41kVeri yok
Phillip Monk
Chairman of Scientific Advisory Board15.2yrsUK£241.00k0.21%
£ 20.2k
Donna Davies
Co-Founder & Member of Scientific Advisory Boardno dataVeri yokVeri yok
Ratko Djukanovic
Co-Founder & Member of Scientific Advisory Boardno dataVeri yokVeri yok
Mark Parry-Billings
Chairmanless than a yearVeri yokVeri yok
David Campbell
Non-Executive Director & Member of Scientific Advisory Board18.6yrsUK£40.00k0.16%
£ 15.8k
Felicity Gabbay
Member of Scientific Advisory Board & Independent Non-Executive Director2.2yrsUK£45.00kVeri yok
Amanda Radford
Independent Non-Executive Director1.9yrsUK£45.00kVeri yok

8.7yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SNG's board of directors are considered experienced (8.7 years average tenure).